Diagnostic challenges in subcorneal pustular dermatosis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Subcorneal pustular dermatosis, also known as Sneddon–Wilkinson disease, is a rare recurrent condition, and its nosology remains a subject of debate. It is often placed within the spectrum of bullous dermatoses and interpreted as a subtype of pemphigus; however, some contemporary studies consider it a neutrophilic dermatosis, and even a potential variant of pustular psoriasis.

Clinically, Sneddon–Wilkinson disease presents with eruptions on normal or erythematous skin in the form of flaccid, superficial, small (2–4 mm) sterile pustules, which are often grouped, forming annular or garland-like patterns. The process is typically symmetrical.

The etiopathogenesis remains incompletely understood, though current evidence indicates that the key pathogenic mechanism is the accumulation of neutrophils beneath the stratum corneum, possibly due to an abnormal neutrophilic response to aberrant chemotactic factors located within the upper epidermal layers.

Diagnosis of Sneddon–Wilkinson disease is challenging, because its clinical presentation closely resembles several other conditions. Another difficulty is in the need to distinguish subcorneal pustular dermatosis from pustular psoriasis. Diagnosis is based on clinical presentation and histopathological examination, where subcorneal neutrophilic accumulation is key.

The issue of treatment for this type of dermatosis remains relevant, with dapsone being the first-line option. In cases of poor response or contraindications, alternative modalities may be used, including systemic glucocorticoids, retinoids, PUVA therapy, and tumor necrosis factor-α (TNF-α) inhibitors.

This article presents a rare clinical case of Sneddon–Wilkinson disease in a 20-year-old pregnant patient in her second trimester, with a year-long disease history, diagnostic difficulties, and challenges in therapeutic management.

About the authors

Olga Y. Olisova

The First Sechenov Moscow State Medical University

Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754
SPIN-code: 2500-7989

MD, Dr. Sci. (Medicine), Professor, Corresponding Member of the Russian Academy of Sciences

Russian Federation, Moscow

Natalya P. Teplyuk

The First Sechenov Moscow State Medical University

Email: teplyukn@gmail.com
ORCID iD: 0000-0002-5800-4800
SPIN-code: 8013-3256

MD, Dr. Sci. (Medicine), Professor

Russian Federation, Moscow

Olga V. Grabovskaya

The First Sechenov Moscow State Medical University

Email: olgadoctor2013@yandex.ru
ORCID iD: 0000-0002-5259-7481
SPIN-code: 1843-1090

MD, Cand. Sci. (Medicine), Professor

Russian Federation, Moscow

Ekaterina V. Grekova

The First Sechenov Moscow State Medical University

Author for correspondence.
Email: grekova_kate@mail.ru
ORCID iD: 0000-0002-7968-9829
SPIN-code: 8028-5545

MD, Cand. Sci. (Medicine), Assistant Professor

Russian Federation, Moscow

Anastasia V. Shepeleva

The First Sechenov Moscow State Medical University

Email: dr.shepelevaavl@gmail.com
ORCID iD: 0009-0001-5251-5394
Russian Federation, Moscow

Anisa S. Zokirova

The First Sechenov Moscow State Medical University

Email: zokirovaanisa@mail.ru
ORCID iD: 0009-0008-9694-9363
Russian Federation, Moscow

Goarik A. Bagdasaryan

The First Sechenov Moscow State Medical University

Email: goga05022001@yandex.ru
ORCID iD: 0009-0004-0638-6992
Russian Federation, Moscow

Anastasiia А. Miagkova

The First Sechenov Moscow State Medical University

Email: myan_03@mail.ru
ORCID iD: 0009-0007-7602-0162
Russian Federation, Moscow

References

  1. Romagnuolo M, Muratori S, Cattaneo A, et al. Successful treatment of refractory Sneddon-Wilkinson disease (subcorneal pustular dermatosis) with infliximab. Dermatol Ther. 2022;35(7):e15552. doi: 10.1111/dth.15552 EDN: ANEMIW
  2. Drozhdina MB, KoshkiN SV. Sneddon-Wilkinson disease: review of the modern literature. Vestnik dermatologii i venerologii. 2019;95(1):15–20. doi: 10.25208/0042-4609-2019-95-1-15-20 EDN: FXIFZK
  3. Cheng S, Edmonds E, Ben-Gashir M, et al. Subcorneal pustular dermatosis: 50 years on. Clin Exp Dermatol. 2008;33(3):229–233. doi: 10.1111/j.1365-2230.2008.02706.x
  4. Sneddon IB, Wilkinson DS. Subcorneal pustular dermatosis. Br J Dermatol. 1979;100(1):61–68. doi: 10.1111/j.1365-2133.1979.tb03570.x
  5. Dyudyun AD, Romanenko KV, Ivneva SV, et al. A clinical case of subcorneal pustular dermatosis (Sneddon-Wilkinson disease) on the background of atopic dermatitis. Dermatovenerology. Cosmetology. Sexopathology. 2015;(3-4):216–222. EDN: WMFPSH
  6. Watts PJ, Khachemoune A. Subcorneal pustular dermatosis: a review of 30 years of progress. Am J Clin Dermatol. 2016;17(6):653–671. doi: 10.1007/s40257-016-0202-8 EDN: TRQTAU
  7. Naik HB, Cowen EW. Autoinflammatory pustular neutrophilic diseases. Dermatol Clin. 2013;31(3):405–425. doi: 10.1016/j.det.2013.04.001
  8. Alhafi MA, Janahi MI, Almossalli ZN. Subcorneal pustular dermatosis in paediatrics: a case report and review of the literature. Cureus. 2021;13(12):e20221. doi: 10.7759/cureus.20221 EDN: AXYQOF
  9. Karacheva YV, Smykova AN. Subcorneal pustular dermatosis of Sneddon-Wilkinson: сlinical case. Russian Journal of Skin and Venereal Diseases. 2018;21(1):28–30. doi: 10.18821/1560-9588-2018-21-1-28-30 EDN: UTYSTY
  10. Raznatovskii KI, Piriatinskaia VA, Kariakina LA, et al. Pustular dermatosis (Sneddon-Wilkinson disease): case study. Russian Journal of Clinical Dermatology and Venereology. 2017;16(3):36–40. doi: 10.17116/klinderma201716336-39 EDN: ZCIMNJ
  11. Tajiri K, Nakajima T, Kawai K, et al. Sneddon-Wilkinson disease induced by sorafenib in a patient with advanced hepatocellular carcinoma. Intern Med. 2015;54(6):597–600. doi: 10.2169/internalmedicine.54.3675
  12. Iurillo A, YumeeN S, Imbriano D, et al. Subcorneal pustular dermatosis following SARS-CoV-2 infection. R I Med J (2013). 2023;106(10):51–53.
  13. Johnston A, Xing X, Wolterink L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017;140(1):109–120. doi: 10.1016/j.jaci.2016.08.056
  14. Abreu Velez AM, Smith JG, Howard MS. Subcorneal pustular dermatosis an immnohisto-pathological perspective. Int J Clin Exp Pathol. 2011;4(5):526–529. EDN: YCUDMX
  15. Razera F, Olm GS, Bonamigo RR. Neutrophilic dermatoses: part II. An Bras Dermatol. 2011;86(2):195–211. doi: 10.1590/s0365-05962011000200001
  16. Delaleu J, Lepelletier C, Calugareanu A, et al. Neutrophilic dermatoses. Rev Med Interne. 2022;43(12):727–738. doi: 10.1016/j.revmed.2022.06.007 EDN: XWKBPD
  17. Hensley CD, Caughman SW. Neutrophilic dermatoses associated with hematologic disorders. Clin Dermatol. 2000;18(3):355–367. doi: 10.1016/s0738-081x(99)00127-3
  18. Delaporte E, Colombel JF, Nguyen-Mailfer C, et al. Subcorneal pustular dermatosis in a patient with Crohn’s disease. Acta Derm Venereol. 1992;72(4):301–302. doi: 10.2340/0001555572301302
  19. Butt A, Burge SM. Sneddon-Wilkinson disease in association with rheumatoid arthritis. Br J Dermatol. 1995;132(2):313–315. doi: 10.1111/j.1365-2133.1995.tb05037.x
  20. Ishii N. Significance of anti-desmocollin autoantibodies in pemphigus. J Dermatol. 2023;50(2):132–139. doi: 10.1111/1346-8138.16660 EDN: ITVIWH
  21. Brodehl A, Stanasiuk C, Anselmetti D, et al. Incorporation of desmocollin-2 into the plasma membrane requires N-glycosylation at multiple sites. FEBS Open Bio. 2019;9(5):996–1007. doi: 10.1002/2211-5463.12631
  22. Abdelhafez MM, Ahmed KA, Mohd Daud MN, et al. Impetigo herpetiformis: a rare pregnancy-specific dermatosis. Obset Med. 2023;16(1):5–8. doi: 10.1177/175349X221074610 EDN: BLIDOC
  23. Borzova IYu, Vertieva EYu, Grabovskaya OV, et al. An illustrated guide to dermatology: to prepare doctors for accreditation. Olisova OYu, Teplyuk NP, editors. Moscow: GEOTAR-Media; 2023. 373 p. (In Russ.)
  24. Sheu JS, Divito SJ, Enamandram M, et al. Dapsone therapy for pustular psoriasis: case series and review of the literature. Dermatology. 2016;232(1):97–101. doi: 10.1159/000431171
  25. Kretschmer L, Maul JT, Hofer T, et al. Interruption of Sneddon-Wilkinson subcorneal pustulation with infliximab. Case Rep Dermatol. 2017;9(1):140–144. doi: 10.1159/000468917
  26. Guerin C, Beylot-Barry M, Frouin E, et al. Treatment of subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with anti-tumor necrosis factor alpha. Cureus. 2021;13(8):e17147. doi: 10.7759/cureus.17147 EDN: BBOSML
  27. Keller M, Spanou Z, Schaerli P, et al. T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol. 2005;175(11):7678–7686. doi: 10.4049/jimmunol.175.11.7678
  28. Nakamizo S, Kobayashi S, Usui T, et al. Clopidogrel-induced acute generalized exanthematous pustulosis with elevated Th17 cytokine levels as determined by a drug lymphocyte stimulation test. Br J Dermatol. 2010;162(6):1402–1403. doi: 10.1111/j.1365-2133.2010.09705.x
  29. Ono S, Otsuka A, Miyachi Y, et al. Subcorneal pustular dermatosis exhibiting a high serum TARC/CCL17 level. Case Rep Dermatol. 2013;5(1):38–42. doi: 10.1159/000348241
  30. Kaminski VL, Ellwanger JH, Matte MC, et al. IL-17 bloods levels increase in healthy pregnancy but not in spontaneous abortion. Mol Biol Rep. 2018;45(5):1565–1568. doi: 10.1007/s11033-018-4268-7 EDN: FBLTSA
  31. Wanberg LJ, Schultz B, Goyal A. Treatment of subcorneal pustular dermatosis without dapsone: a case report and review of the literature. Case Rep Dermatol Med. 2024;2024:8140483. doi: 10.1155/2024/8140483 EDN: KEQAFG
  32. Korbi M, Amri F, Njima M, et al. Successful treatment of Sneddon-Wilkinson disease with doxycycline. Clin Exp Dermatol. 2021;46(8):1568–1569. doi: 10.1111/ced.14756 EDN: KZMFUU
  33. Ceccarelli G, Molinelli E, Campanati A, et al. Sneddon-Wilkinson disease and monoclonal gammopathy of undetermined significance in the elderly: case report. Case Rep Dermatol. 2019;11(2):209–214. doi: 10.1159/000487003
  34. Karadoğan SK, Aydoğan K, Başkan EB, et al. A case of subcorneal pustular dermatosis treated successfully with a combination of cyclosporin and prednisolone. J Eur Acad Dermatol Venereol. 2007;21(4):536–537. doi: 10.1111/j.1468-3083.2006.01929.x
  35. Magdaleno-Tapial J, Valenzuela-Oñate C, Alonso-Carpio M, et al. Improvement of recalcitrant Sneddon-Wilkinson disease with apremilast. Australas J Dermatol. 2020;61(2):185–186. doi: 10.1111/ajd.13253 EDN: DGWWNF
  36. Hoshina D, Tsujiwaki M, Furuya K. Successful treatment of subcorneal pustular dermatosis with maxacalcitol. Clin Exp Dermatol. 2016;41(1):102–103. doi: 10.1111/ced.12680
  37. Yamaguchi Y, Oyama N, Koizumi H, et al. Successful treatment of recalcitrant subcorneal pustular dermatosis with oral nicotinamide. J Dermatol. 2019;46(11):e438–e440. doi: 10.1111/1346-8138.14980
  38. Falcone LM, Pilcher MF, Kovach RF, et al. Pentoxyfilline as a treatment for subcorneal pustular dermatosis. Dermatol Ther. 2019;32(2):e12818. doi: 10.1111/dth.12818

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2025 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).